marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Aurinia Pharmaceuticals Financial Statements 2011-2024 | AUPH
Annual Financial Statements Aurinia Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
874 M | 1.29 B | 1.59 B | 1.66 B | 1.63 B | 539 M | 424 M | 113 M | 64.3 M | 97.7 M | - | - | - |
Shares |
143 M | 142 M | 129 M | 118 M | 93 M | 84.8 M | 76.9 M | 35.3 M | 32.2 M | 29.2 M | - | - | - |
Historical Prices |
6.1 | 9.1 | 12.3 | 14 | 17.5 | 6.75 | 5.21 | 3.56 | 2.37 | 4.7 | - | - | - |
Net Income |
-26.9 M | -26 M | -181 M | -103 M | -124 M | -64.1 M | -70.8 M | -23.3 M | -18.6 M | -16.6 M | -2.55 M | -9.74 M | -2.41 M |
Revenue |
45.1 M | 28.4 M | 45.6 M | 50.1 M | 318 K | 463 K | 420 K | 173 K | 235 K | 278 K | 949 K | 6.16 M | 928 K |
Cost of Revenue |
14.1 M | 5.66 M | 1.09 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | -52.5 M | -40.9 M | -33.5 M | -14.4 M | -15.8 M | -8.87 M | -986 K | 602 K | 742 K |
Operating Income |
-29.7 M | -28.1 M | -181 M | -104 M | -90.9 M | -55.2 M | - | - | - | - | - | - | - |
Interest Expense |
2.78 M | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-18 M | -25.4 M | -178 M | -103 M | -74.7 M | -54.6 M | -45.6 M | -21.3 M | -22 M | -15.8 M | -3.22 M | -4.62 M | -5.48 M |
Operating Expenses |
74.8 M | 56.5 M | 56.1 M | 97.3 M | 23.7 M | 15.2 M | 13.6 M | 8.45 M | 7.82 M | 8.41 M | 3.04 M | 6.07 M | 7.18 M |
General and Administrative Expenses |
195 M | 196 M | 174 M | 97.3 M | 22.2 M | 13.7 M | 12.1 M | 6.97 M | 6.26 M | 6.89 M | 2.23 M | 3.9 M | 2.74 M |
All numbers in USD currency
Quarterly Income Statement Aurinia Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
143 M | 143 M | 144 M | 144 M | 143 M | 143 M | 143 M | 142 M | 142 M | 142 M | 142 M | 142 M | 128 M | 128 M | 127 M | 127 M | 122 M | 113 M | 112 M | 112 M | - | - | - | 85.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
14.4 M | 722 K | -10.7 M | - | -13.4 M | -11.5 M | -26.2 M | - | -8.99 M | -35.5 M | -37.6 M | -33.3 M | -50.3 M | -47 M | -50.4 M | -8.07 M | -42.1 M | -26.5 M | -25.9 M | -34.5 M | -23.5 M | -16.4 M | -14.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
67.8 M | 57.2 M | 50.3 M | - | 54.5 M | 41.5 M | 34.4 M | - | 55.8 M | 28.2 M | 21.6 M | 23.4 M | 14.7 M | 6.62 M | 914 K | 50 M | 29 K | 29 K | 30 K | 29 K | 230 K | 29 K | 30 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
6.04 M | 8.91 M | 7.75 M | - | 6.77 M | 1.56 M | 421 K | - | 2.45 M | 1.6 M | 256 K | - | 254 K | 308 K | 48 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
11.7 M | -1.51 M | -13.3 M | - | -16.3 M | -16.2 M | -29.6 M | - | -9.5 M | -36 M | -37.9 M | -32.7 M | -50.4 M | -47.1 M | -50.5 M | -8.05 M | -42.3 M | -26.9 M | -27.1 M | -34.8 M | -24.1 M | -17.1 M | -14.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | 1.2 M | 1.28 M | - | 1.4 M | 65 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
11.9 M | -1.31 M | -8.41 M | - | -15.8 M | -15.7 M | -28.9 M | - | -9 M | -35.5 M | -37.2 M | -32.7 M | -48.3 M | -46.9 M | -49.9 M | -8.05 M | -42.3 M | -26.9 M | -27 M | -34.8 M | -24.1 M | -17.1 M | -14.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | 56.1 M | 65 M | 53.8 M | 51.5 M | 58.1 M | 42.3 M | 26.9 M | 27.1 M | 34.9 M | 24.3 M | 17.2 M | 14.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
42.4 M | 44.9 M | 47.7 M | - | 47.8 M | 47.1 M | 50.1 M | - | 52.2 M | 51.5 M | 45.2 M | - | 44.6 M | 43.8 M | 39.8 M | - | 30.7 M | 15.4 M | 11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency